Friday - March 13, 2026

Category Archives: Science

Autosomal Dominant Polycystic Kidney Disease Market Set for Robust Growth by 2034 Amid Advancing Therapeutics Landscape | DelveInsight

The dynamics of the autosomal dominant polycystic kidney disease market are anticipated to change in the coming years, owing to the launch of emerging therapies such as XRx-008 (Xortx Therapeutics), CYX082 (Novartis), AZD1613 (AstraZeneca), VX-407 (Vertex Pharmaceuticals), ABBV-CLS-628 (Calico Life … Continue reading →

Chronic Lymphocytic Leukemia Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline landscape. It covers the Chronic Lymphocytic Leukemia pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Chronic Hepatitis B Virus Treatment Pipeline Shows Strong Momentum as 50+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Chronic Hepatitis B Virus Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus pipeline landscape. It covers the Chronic Hepatitis B Virus pipeline drug profiles, including clinical and nonclinical … Continue reading →

Cholangiocarcinoma Clinical Trial Pipeline Shows Potential with Active Contributions from 55+ Key Companies | DelveInsight

DelveInsight’s, “Cholangiocarcinoma Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cholangiocarcinoma pipeline therapeutics … Continue reading →

Advanced Renal Cell Carcinoma Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Advanced Renal Cell Carcinoma Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the Advanced Renal Cell Carcinoma Pipeline drug profiles, including clinical and nonclinical … Continue reading →

Brain Metastases Clinical Trial Pipeline Expands as 40+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Brain Metastases Pipeline Insights 2026” report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It covers the Brain Metastases pipeline drug profiles, including clinical and nonclinical stage products. Brain Metastases … Continue reading →

Bile Duct Cancer Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Bile Duct Cancer Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Bile Duct Cancer pipeline landscape. It covers the Bile Duct Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Conductive Inks Market Size to Reach USD 4.11 Billion by 2031, Driven by Rising Demand for Flexible Electronics and Photovoltaic Technologies

Conductive Inks Market The “Conductive Inks Market” Insights report offers an in-depth and thorough analysis of the market, covering aspects such as size, shares, revenues, segments, drivers, trends, growth, and development. Additionally, it identifies factors that may limit growth and … Continue reading →

Codex Labs to Showcase Skin-Gut Biome Innovations at Three Major Dermatology Conferences

DENVER, Colo. – March 11, 2026 – Codex Labs, a biotech skincare company focused on integrative dermatology and microbiome-friendly skin-gut solutions, is excited to announce its participation in the Dermatology Nurses’ Association (DNA) 44th annual convention, the Society of Pediatric … Continue reading →

Dr. Tommy Rhee’s Research Accepted for Presentation at the 2026 ASIPP Annual Meeting

Dr. Tommy Rhee’s Research on Cell-Free Regenerative Signaling Accepted for Presentation at 2026 ASIPP Annual Meeting Tampa, FL – Dr. Tommy Rhee, regenerative medicine researcher and founder of RheeGen®, a patent-pending topical regenerative platform, announced that his latest research abstract has … Continue reading →